Core Scientific Inc (CORZQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -502,766 | -356,106 | 580,693 | -1,315,005 | -1,049,464 |
| Depreciation Amortization | 67,740 | 47,256 | 24,139 | 123,877 | 93,328 |
| Accounts receivable | N/A | N/A | 6 | 659 | N/A |
| Accounts payable and accrued liabilities | -17,618 | -16,379 | -14,295 | -12,272 | -11,640 |
| Other Working Capital | 335,529 | 116,731 | 16,595 | 374,824 | -51,919 |
| Other Operating Activity | 242,297 | 201,899 | -647,737 | 870,813 | 1,048,786 |
| Operating Cash Flow | $125,182 | $-6,599 | $-40,599 | $42,896 | $29,091 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -452,265 | -208,030 | -88,422 | -94,961 | -66,203 |
| Purchase Sale Intangibles | -10,160 | -36 | -36 | -231 | -191 |
| Other Investing Activity | -15,160 | -5,036 | -5,036 | -231 | -191 |
| Investing Cash Flow | $-467,425 | $-213,066 | $-93,458 | $-95,192 | $-66,394 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 1,057,765 | 447,609 |
| Debt Repayment | -10,285 | -9,738 | -4,464 | -313,386 | -299,745 |
| Common Stock Issued | 1,746 | 630 | 266 | 59,894 | 56,922 |
| Other Financing Activity | -32,755 | -26,862 | 0 | 15,294 | 16,610 |
| Financing Cash Flow | $-41,294 | $-35,970 | $-4,198 | $819,567 | $221,396 |
| Beginning Cash Position | 836,980 | 836,980 | 836,980 | 69,709 | 69,709 |
| End Cash Position | 453,443 | 581,345 | 698,725 | 836,980 | 253,802 |
| Net Cash Flow | $-383,537 | $-255,635 | $-138,255 | $767,271 | $184,093 |
| Free Cash Flow | |||||
| Operating Cash Flow | 125,182 | -6,599 | -40,599 | 42,896 | 29,091 |
| Capital Expenditure | -454,194 | -209,701 | -88,422 | -94,961 | -66,203 |
| Free Cash Flow | -329,012 | -216,300 | -129,021 | -52,065 | -37,112 |